BioCentury
ARTICLE | Clinical News

ALTU-238: Phase Ic data

January 19, 2009 8:00 AM UTC

Data from 36 healthy volunteers in a dose-escalating, U.S. Phase Ic trial showed that Altus' scaled-up ALTU-238 had similar safety, pharmacokinetic and pharmacodynamic profiles to the compound used in...